Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06311708
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-03-08
Brief Title:
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector AAV9 and the Progression of Disease in Patients with Plakophilin 2 PKP2-associated Arrhythmogenic Right Ventricular Cardiomyopathy ARVC
Sponsor:
Organization:
Tenaya Therapeutics
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Blood samples will be collected throughout the study 1 time each year to assess proteins and biomarkers associated with ARVC and to study existing antibodies to AAV9
Enrollment Count:
200
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Other |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 104774 |
Who Masked List: